Innovation Pharmaceuticals Inc (IPIX)

[PJ007]

This is also from the same company (Biosynth)website: Interesting…,

ZYB09599
Brilacidin tetrahydrochloride

Brilacidin tetrahydrochloride is an analog of a naturally occurring peptide that has been shown to have anticancer properties. It works by inhibiting the activity of kinases, which are enzymes that play a critical role in cancer cell growth and survival. Brilacidin tetrahydrochloride has been shown to induce apoptosis, or programmed cell death, in tumor cells. In addition to its anticancer effects, this compound also has potential as an inhibitor of protein kinase C (PKC), which is involved in a variety of signaling pathways. Brilacidin tetrahydrochloride has been studied in Chinese hamster ovary cells and human urine samples, and it shows promising results as a potential anticancer agent. It may also have potential therapeutic applications for other diseases such as dabigatran-induced nephropathy.